The nuclear factor kappa-B (NF-κB) was usually overexpressed in a subset of HER2-positive breast cancers, and its upregulation was related to the metastatic potential of HER2 overexpressed tumors. This evidence concerns the gene ERBB2 and breast carcinoma.